Infusion Center Valuation
Infusion Services Business Valuation Calculator & Exit Planning Built for Infusion Center Owners
We built one platform that tracks your infusion center's value monthly, identifies exit gaps early, and ensures your personal finances align with your exit timeline.
1,000+ Businesses have joined YourExitValue.com
Most Infusion Center Owners Have No Idea What Their Business is Actually Worth
Current Infusion Services Valuation Multiples (2026)
Infusion center valuations are growing due to site-of-care shift. Here's the market:
Every business is different. That's why you need to track your value.
Included in Your Exit Value is a complete Exit Planning Assessment where you track your progress quarterly against your results from the previous quarter.
Know your number and watch it grow
Most business owners guess at their value. You'll know it with precision.
Our platform uses six proven valuation methodologies to give you a complete picture of what your business is worth today—and tracks how that number changes month over month. No more waiting for annual appraisals or paying $15K+ for outdated reports.
See your trends. Spot opportunities. Make informed decisions
What Actually Drives Infusion Center Value
Your patient care matters, but sophisticated buyers evaluate these factors that determine premium pricing:
Patient Volume
Growing Infusion Visits
Monthly infusion visits drive center economics. Track patient volume by therapy type. Growing volume demonstrates market demand and referral relationships. Declining volume raises concerns about competition or referral source stability.
Declining volume = buyer concern
Drug Mix
High-Value Specialty Drugs
Not all infusions are equal—specialty biologics for rheumatology, GI, and oncology often have better economics than basic hydration. Understanding your drug mix helps assess revenue quality. Centers with specialty drug focus may command better valuations.
Basic only = limited margins
Payer Contracts
In-Network with Major Payers
In-network contracts with commercial payers and proper Medicare/Medicaid enrollment determine patient access and reimbursement rates. Strong payer relationships and favorable contract rates improve economics. Evaluate your contract portfolio and rate competitiveness.
Poor contracts = revenue limits
Physician Referrals
Diversified Specialist Referrals
Infusion patients come from specialists—rheumatologists, gastroenterologists, oncologists, infectious disease. Diversified referral relationships provide sustainable patient flow. Concentration with few referring physicians creates risk. Build and document your referral network.
Concentrated referrals = vulnerable
Accreditation
ACHC or URAC Accredited
Accreditation from ACHC, URAC, or similar bodies demonstrates quality standards and often enables better payer contracts. Accredited centers have competitive advantages over non-accredited competitors. Investment in accreditation typically pays off.
No accreditation = payer limits
Operational Efficiency
High Chair Utilization
How efficiently do you utilize your infusion chairs? Chair utilization indicates operational efficiency. High utilization demonstrates capacity optimization. Track infusions per chair per day; it's a key efficiency metric.
Low utilization = efficiency gap
How to Value an Infusion Services Business
The U.S. outpatient infusion services market has grown rapidly as healthcare shifts away from hospital-based infusion toward lower-cost ambulatory settings. Infusion centers administer IV medications for conditions including autoimmune diseases, cancer, infections, and nutritional deficiencies.
EBITDA is the primary valuation method. Infusion services businesses typically sell for 5.0x to 10.0x EBITDA, reflecting the sector's strong growth, recurring patient relationships, and favorable reimbursement environment.
Revenue multiples generally range from 0.75x to 1.5x annual revenue. Centers with in-network contracts with major payers and a diversified drug mix command the upper end.
The unique valuation driver for infusion centers is the drug mix, payer contracts, and nursing staff. Different infusion drugs carry dramatically different reimbursement rates and margins. Centers administering high-cost specialty biologics (Remicade, Rituxan, Entyvio) generate substantial revenue per chair per day. In-network contracts with commercial payers at favorable rates are critical assets. Infusion-trained nurses are the operational backbone, and staffing stability directly impacts capacity and quality.
The outpatient infusion sector has attracted significant PE investment as the site-of-care shift accelerates. Companies like Option Care Health, Orsini, and BioMatrix are active acquirers. Use our free calculator above to get your instant estimate, then track your value monthly with YourExitValue.
Frequently Asked Questions
What multiple do infusion centers sell for?
Infusion centers typically sell for 3.5x – 6.5x SDE or 6x – 11x EBITDA. Centers with specialty drug mix, strong payer contracts, and accreditation command premium multiples.
How does drug mix affect infusion center value?
Significantly. Specialty biologics for rheumatology, GI, and oncology often have better economics than basic infusions. Drug mix affects revenue quality and margins.
Who buys infusion centers?
National infusion companies, PE-backed infusion platforms, specialty pharmacy companies adding infusion, hospital systems, and physician groups building infusion capability.
Does accreditation affect infusion center value?
Yes. ACHC, URAC, or similar accreditation demonstrates quality and often enables better payer contracts. Accredited centers have advantages over non-accredited competitors.
How important are referral relationships?
Critical. Infusion patients come from specialists. Diversified referral relationships provide sustainable volume. Concentration creates risk.
What's the fastest way to increase my infusion center value?
Three high-impact moves: 1) Pursue accreditation (ACHC, URAC), 2) Develop specialty drug programs for higher-value therapies, 3) Diversify specialist referral relationships.